港交所(00388.HK):新股市场集资金额有望创2010年以来新高
香港交易所(00388.HK)指,自2018年改革上市制度後,港交所继续致力缔造更有动力、更多元化的香港市场,并取得显着成效,吸引了不少新股来港作主要上市及第二上市,有助推动本地市场结构转型,年初至今来自新经济公司的上市集资额比去年同期更上升逾61%。香港已建立了亚洲最蓬勃的科技及新经济公司金融生态系统。
港交所认为新股市场集资金额有望创2010年以来的新高,当中新经济公司占上市新规实施以来(截至今年12月10日)香港整个新股市场集资总额近60%,新经济公司对股票市场平均每日成交金额的占比不断增加,由2018年的4.1%增至2020年11月的22.8%。短短几年香港已成为全球第二大生物科技融资中心,自上市新规生效以来,已迎来47家医疗健康和生物科技公司在香港主板上市。(el/k) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.